By suppressing ROR-driven BMAL1 transcription, it reduces IL-17 production in autoimmune models–a mechanism particularly relevant for uveitis and lupus nephritis (Wang et al., 2010; Ribeiro et al., 2021). Here, IL17A is linked to uveitis.